PMC full text:
Clin Gastroenterol Hepatol. Author manuscript; available in PMC 2019 Jan 1.
Published in final edited form as:
Clin Gastroenterol Hepatol. 2018 Jan; 16(1): 99–105.
Published online 2017 Sep 1. doi: 10.1016/j.cgh.2017.08.041Table 2
Characteristics of women with available infant vaccine titers
| Characteristic | Biologic exposed (n=42) | Biologic unexposed (n=8) |
|---|---|---|
| Mean age (in years) (SD) | 31.7 (3.4) | 30.6 (4.4) |
| Mean disease duration (in years) (SD) | 10.4 (5.6) | 5.3 (2.3) |
| Type of IBD (%) | ||
| Crohn’s disease | 30 (71.4) | 4 (50.0) |
| Ulcerative colitis | 11 (26.2) | 4 (50.0) |
| IBDU | 1 (2.4) | 0 (0.0) |
| Ever smoker (%) | 5 (11.9) | 2 (25.0) |
| Disease activity (%) | ||
| None | 34 (81.0) | 5 (62.5) |
| Mild | 8 (19.0) | 3 (37.5) |
| Medication use [N(%)] | ||
| Biologics | 42 (100.0) | 0 (0.0) |
| Immunomodulators | 10 (23.8) | 2 (25.0) |
| 5-ASA, steroids, antibiotics, or no therapy | N/A | 6 (75.0) |
IBD – inflammatory bowel disease; IBDU – IBD unspecified; N/A – not applicable